Equity Analysis /
United States of America

US : Antares Pharma, Inc. - ATRS | Weekly Rx Metrics: Double-Digit Y/Y Epi Growth Subsides as Fall RX Push Worked Through

    Michael Parolari
    Michael Parolari

    Research Associate

    Follow
    CGS-CIMB
    27 December 2021
    Published byCGS-CIMB